Brainstorm Cell Therapeutics | BCLI - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Biogen USD 647.3M 269.6M 2026-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cipla INR 10.82B 3.33B 2026-06
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Mesoblast USD 39.72M 93.81M 2025-12